INDP Earnings Indaptus Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–16 of 16
| Q1 2026 | 2026-03-31 | -0.23 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -21.58 | 2026-03-17 | 10-K |
| Q3 2025 | 2025-09-30 | -18.48 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -18.09 | 2025-08-13 | 10-Q |
| Q1 2026 | 2025-03-31 | -9.11 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -44.96 | 2026-03-17 | 10-K |
| Q3 2025 | 2024-09-30 | -34.53 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -25.79 | 2025-08-13 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.45 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -1.83 | 2025-03-13 | 10-K |
| Q3 2024 | 2023-09-30 | -1.36 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.89 | 2024-08-12 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.51 | 2024-05-08 | 10-Q |
| FY 2023 | 2022-12-31 | -1.73 | 2024-03-13 | 10-K |
| Q3 2023 | 2022-09-30 | -1.29 | 2023-11-06 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.87 | 2023-08-14 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.